Pancreastatin secretion by pituitary adenomas and regulation of chromogranin B mRNA expression

American Journal of Pathology

Volumn 148, Issue 6, 1996, Pages 2057-2066

  Jin, Long ^a   Scheithauer, Bernd W ^a   Young Jr , William F ^a   Davis, Dudley H ^a   Klee, George G ^a   Lloyd, Ricardo V ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; CHROMOGRANIN B; FOLLITROPIN; GONADORELIN; HYPOPHYSIS HORMONE; HYPOTHALAMUS HORMONE; INSULIN; MESSENGER RNA; PANCREASTATIN; PARATHYROID HORMONE; PROLACTIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOREACTIVITY; MALE; NULL CELL; PRIORITY JOURNAL; PROLACTINOMA;

ADENOMA; ADULT; AGED; CHILD; CHROMOGRANIN B; CHROMOGRANINS; FEMALE; HUMANS; HYPOTHALAMIC HORMONES; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PANCREATIC HORMONES; PITUITARY HORMONES; PITUITARY NEOPLASMS; PROLACTINOMA; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0030001474     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Wiedenmann B, Huttner WB: Synaptophysin and chromogranins/secretogranins: widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis. Virchows Arch B Cell Pathol 1989, 58:95-121
2. Huttner WB, Gerdes H-H, Rosa P: The granin (chromogranin/secretogranin) family. Trends Biochem Sci 1991, 16:27-30
3. Winkler H, Fischer-Colbrie R: The chromogranins A and B: the first 15 years and future perspectives. Neuroscience 1992, 49:497-528
4. Rosa P, Gerdes H-H: The granin protein family: markers for neurodendocrine cells and tools for the diagnosis of neuroendocrine tumors. J Endocrinol Invest 1994, 17:207-225
5. Mouland AJ, Bevan S, White JH, Hendy GN: Human chromogranin A gene: molecular cloning, structural analysis, and neuroendocrine cell-specific expression. J Biol Chem 1994, 269:6918-6926
6. Hendy GN, Bevan S, Mattei M-G, Mouland AJ: Chromogranin A. Clin Invest Med 1995, 18:47-65
7. Tatemoto K, Efendic S, Mutt V, Makk G, Feistner GJ, Barchas JD: Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 1986, 324:476-478
8. Fasciotto BH, Trauss CA, Greeley GH, Conn DV: Parastatin (porcine chromogranin A 347-419), a novel chromogranin A-derived peptide, inhibits parathyroid cell secretion. Endocrinology 1993, 133:461-466
9. Konecki DS, Benedum UM, Gerdes HH, Huttner WB: The primary structure of human chromogranin A and pancreastatin. J Biol Chem 1987, 262:17026-17030
10. Schmidt WE, Siegel EG, Lamberts R, Gallwitz B, Creutzfeldt W: Pancreastatin: molecular and immunocytochemical characterization of a novel peptide in porcine and human tissues. Endocrinology 1988, 123: 1395-1404
11. Kar S, Brethertony-Watt D, Gibson SJ, Steel JH, Gentleman SM, Roberts GW, Valentino K, Tatemoto K, Ghatei MA, Bloom SR, Polak JM: Novel peptide pancreastatin: its occurrence and codistribution with chromogranin A in the central nervous system of the pig. J Comp Neurol 1989, 288:627-639
12. Tateishi K, Funakoshi A, Wakasugi H, Iguchi H, Shinozaki H, Abe M, Funakosha S, Tamamura H, Yajima H, Matsuoka Y: Plasma pancreastatin-like immunoreactivity in various diseases. J Clin Endocrinol Metab 1989, 69:1305-1308
13. Yasuda D, Iguchi H, Funakoshi A, Wakagusi H, Sekiya K, Misawa T, Tateishi K, Bloom SR, Nawata H: Comparison of plasma pancreastatin and GAWK concentrations, presumed processing products of chromogranin A and B, in plasma of patients with pancreatic islet cell tumors. Horm Metab Res 1993, 25:593-595
14. McGrath-Linden SJ, Johnston CF, O'Connor DT, Shaw C, Buchanan KD: Pancreastatin-like immunoreactivity in human carcinoid disease. Regul Pept 1995, 33: 55-70
15. Kitayama N, Tateishi K, Funakoshi A, Miyasaka K, Shimazoe T, Kono A, Iwamoto N, Matsuoka Y: Pancreastatin molecular forms in normal human plasma. Life Sci 1994, 54:1571-1578
16. Robberecht P, Lingier P, Wousson-Colle M-C: Current status on chromogranin A and pancreastatin. Acta Gastroenterol Belgica 1993, 56:261-263
17. Syversen U, Jacobsen MB, O'Connor DT, Ronning K, Waldum HL: Immunoassays for measurement of chromogranin A and pancreastatin-like immunoreactivity in humans: correspondence in patients with neuroendocrine neoplasia. Neuropeptides 1994, 26:201-206
18. Jin L, Chandler WF, Smart JB, England BG, Lloyd RV: Differentiation of human pituitary adenomas determines the pattern of chromogranin/secretogranin messenger ribonucleic acid expression. J Clin Endocrinol Metab 1993, 76:728-738
19. Lloyd RV, Jin L, Qian X, Scheithauer BW, Young WF Jr, Davis DH: Analysis of the chromogranin A post-transcriptional cleavage product pancreastatin and the prohormone convertases PC2 and PC3 in normal and neoplastic human pituitaries. Am J Pathol 1995, 146: 1188-1198
20. Jameson JL, Klibanski A, Black PM, Zervas NT, Lindell CM, Hsu DW, Ridgeway EC, Habener JF: Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas. J Clin Invest 1987, 80: 1472-1478
21. Kwekkeboom DJ, DeJong FH, Lamberts SWJ: Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine. J Clin Endocrinol Metab 1989, 68:1128-1135
22. Song J, Jin L, Chandler WF, England BG, Smart JB, Landefeld TD, Lloyd RV: Gonadotropin-releasing hormone regulates gonadotropin B-subunit and chromogranin-B messenger ribonucleic acids in cultured chromogranin-A-positive pituitary adenomas. J Clin Endocrinol Metab 1990, 71:622-630
23. Asa SL, Cheng Z, Ramyar L, Singer W, Kovacs K, Smyth HS, Muller P: Human pituitary null cell adenomas and oncoytomas in vitro: effects of adenohypophysiotrophic hormone and gonadal steroids in hormone secretion and tumor cell morphology. J Clin Endocrinol Metab 1992, 74:1128-1134
24. Daneshdoost L, Gennarelli TA, Bashey TM, Savino PJ, Sergott RC, Bosley TM, Synder PJ: Identification of gondotroph adenomas in men with clinically nonfunctioning adenomas by the luteinizing hormone B-subunit response to thyrotropin-releasing hormone. J Clin Endocrinol Metab 1993, 77:1352-1355
25. Katznelson L, Alexander JM, Klibanski A: Clinically nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 1993, 76:1089-1094
26. Lloyd RV, Jin L, Fields K, Chandler WF, Horvath E, Stefaneaunu L, Kovacs K: Analysis of pituitary hormones and chromogranin A mRNAs in null cell adenomas, oncocytomas and gonadotroph adenomas in situ hybridization. Am J Pathol 1991, 139:553-564
27. Kovacs K, Horvath E: Tumors of the Pituitary Gland: Atlas of Tumor Pathology, series 2, fascicle 21. Washington, DC, Armed Forces Institute of Pathology, 1986
28. Kovacs K, Asa SL, Horvath E, Ryan N, Singer W, Killinger DW, Smythe HW, Scheithauer BW, Ebersold MJ: Null cell adenomas of the pituitary: attempts to resolve their cytogenesis. Endocrinol Pathol Update 1990, 1:17-31
29. Ahren B, Lindskog S, Tatemoto K, Effendic S: Pancreastatin inhibits insulin secretion and stimulates glucagon secretion in mice. Diabetes 1988, 37:281-285
30. Ridefelt P, Hellman P, Stridsbery M, Akerström G, Rastad J: Different secretory actions of pancreastatin in bovine and human parathyroid cells. Biosci Rep 1994, 14:221-229
31. Gorr SV, Pence SS: Pancreastatin stimulates secretion from neonatal rat atrial cells. J Mol Cardiol 1995, 27: 767-771
32. Galindo E, Rill A, Bader M-F, Aunis D: Chromostatin, a 20-amino-acid peptide derived from chromogranin A, inhibits chromaffin cell secretion. Proc Natl Acad Sci USA 1991, 88:1426-1430
33. Galindo E, Mendez M, Calvo S, Gonzalez-Garcia C, Cena V, Hubert P, Bader M-F, Aunis D: Chromostatin receptors control calcium channel activity in adrenal chromaffin cells. J Biol Chem 1992, 267:407-412
34. Cetin Y, Aunis D, Bader M-F, Galindo G, Jorns A, Bargten G, Grube D: Chromostatin, a chromogranin A-derived bioactive peptide is present in human pancreatic (B) cells. Proc Natl Acad Sci USA 1993, 90: 2360-2364
35. Correction: Proc Natl Acad Sci USA 1994, 91:832
36. Zhang JX, Fasciotto BH, Darling DS, Cohn DV: Pancreastatin, a chromogranin A-derived peptide inhibits transcription of the parathyroid hormone and chromogranin A genes and decreases the stability of the respective messenger ribonucleic acids in parathyroid cells in culture. Endocrinology 1994, 134:1310-1316
37. Kirchmair R, Gee P, Hogue-Angeletti R, Laslop A, Fischer-Colbrie R, Winkler H: Immunological characterization of the endoproteases PC1 and PC2 in adrenal chromaffin granules and in the pituitary gland. FEBS Lett 1992, 297:302-305
38. Zhou A, Mains RE: Endoproteolytic processing of proopiomelanocortin and prohormone convertases 1 and 2 in neuroendocrine cells overexpressing prohormone convertases 1 or 2. J Biol Chem 1994, 269:17440-17447
39. Hashimoto K, Koga M, Kouhara H, Arita N, Hayakawa T, Kishimoto T, Sato B: Expression patterns of messenger ribonucleic acids encoding prohormone convertases (PC2 and PC3) in human pituitary adenomas. Clin Endocrinol 1994, 41:185-191
40. Iacangelo A, Grimes M, Eiden LE: The bovine chromogranin A gene: structural basis for hormone regulation and generation of biologically active peptides. Mol Endocrinol 1990, 5:1651-1660
41. Wu HJ, Rozanski DJ, Webster NJG, O'Connor DT: Cell type specific gene expression in the neuroendocrine-specific regulatory element in the promoter of chromogranin A, a ubiquitous secretory granule core protein. J Clin Invest 1994, 94:118-129
42. Wu H, Mahata SK, Mahata M, Webster NJG, Parmer RJ, O'Connor DT: A functional cyclic AMP response element plays a crucial role in neuroendocrine cell type-specific expression of the secretory granule protein chromogranin A. J Clin Invest 1995, 96:568-578
43. Pohl JM, Phillips E, Song K, Gerdes H-H, Huttner WB, Rüther U: The organisation of the murine chromogranin B (secretogranin I) gene. FEBS Lett 1990, 262:219-224